

Get the latest on the Hydroxocobalamin shortage in 2026. Learn why it's unavailable, when supply may return, how much it costs, and what to do right now.
If you depend on Hydroxocobalamin — the injectable form of vitamin B12 used to treat pernicious anemia and B12 deficiency — you've probably felt the impact of the ongoing drug shortage. In 2026, finding this medication at your local pharmacy can feel nearly impossible.
This post breaks down everything you need to know: whether Hydroxocobalamin is still in shortage, why it's hard to find, what it costs, what new options exist, and how you can locate it in stock today.
Yes. As of early 2026, Hydroxocobalamin injection remains in short supply across the United States. Here's the current situation:
The FDA and ASHP (American Society of Health-System Pharmacists) continue to monitor the shortage and provide updates as they become available.
The current shortage is the result of several overlapping problems:
The main reason the generic IM injection is unavailable is a shortage of the active pharmaceutical ingredient (API) needed to manufacture Hydroxocobalamin. When the raw material supply is disrupted, manufacturers simply can't produce the drug — no matter how much demand exists.
Very few companies manufacture Hydroxocobalamin injection for the U.S. market. Hikma/Actavis is the dominant generic supplier. When that single supplier goes offline, there's no backup capacity to absorb the demand.
Serb Pharmaceuticals' Cyanokit — the IV formulation used for cyanide poisoning — has faced recurring quality concerns. While this formulation serves a different purpose than the routine B12 injection, it further strains the overall Hydroxocobalamin supply chain.
Demand for injectable B12 has been rising. More patients are being diagnosed with B12 deficiency, and wellness clinics and integrative medicine practices have increased their use of B12 injections. This added demand compounds the supply problem.
For more background, read our detailed post on why Hydroxocobalamin is so hard to find.
When you can find it, here's what you can expect to pay:
For more ways to reduce your costs, check out our guide on saving money on Hydroxocobalamin.
Compounding pharmacies have become a critical resource during this shortage. These pharmacies can prepare Hydroxocobalamin injections from raw materials in various concentrations (such as 10 mg/mL or 20 mg/mL). Some ship nationwide, making them accessible to patients across the country.
Several telehealth platforms — including Heally and Hone Health — now offer B12 injection prescriptions online. They partner with compounding pharmacies or specialty pharmacies that may have Hydroxocobalamin in stock, delivering directly to your door.
Many doctors are temporarily switching patients from Hydroxocobalamin to Cyanocobalamin injections, which remain more widely available. While Cyanocobalamin requires more frequent dosing (monthly vs. every 2-3 months), it effectively maintains B12 levels for most patients. Read about all your options in our alternatives guide.
If you're looking for Hydroxocobalamin today, here are the best strategies:
For a comprehensive walkthrough, see our post on how to find Hydroxocobalamin in stock near you.
The Hydroxocobalamin shortage is a real challenge for patients in 2026, but it's not insurmountable. The generic IM injection is expected to return by mid-2026, and in the meantime, compounding pharmacies, telehealth prescriptions, and alternative B12 formulations can help bridge the gap.
The key is to stay proactive: use tools like Medfinder to track availability, talk to your doctor about your options, and don't skip your B12 treatment. B12 deficiency is serious — especially for patients with pernicious anemia — and maintaining consistent treatment protects your nerve health and overall well-being.
Be sure to check out our posts on Hydroxocobalamin side effects and drug interactions for more helpful information about this medication.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.